Announcements

Showing items 5911 - 5920 of 6015 stories.

$1.5M WVU Eye Institute grant to address glaucoma in the Caribbean

Anthony Realini, M.D., M.P.H., a glaucoma specialist in the West Virginia University Eye Institute, has received a $1.5 million grant from the National Eye Institute to conduct a five-year study aimed at finding better ways to address the problem of glaucoma on the Caribbean islands of Dominica and St. Lucia.

WVU Family Medicine residents focus on reaffirming humanity

The process may start with providing basics, such as socks and a sleeping bag. A group of West Virginia University Department of Family Medicine residents offer these necessities to homeless patients who come seeking treatment at Ruby Memorial Hospital. But the true gifts are listening ears, trustworthy advice, and the reaffirmation of humanity – all wrapped into the package of inpatient care for the homeless population.

WVU: Individual reports available to those affected by C8 contamination

West Virginia University, as a steward of the data collected in the 2005-2006 Brookmar C8 Health Project Study, has made individual reports of the study’s findings available to each of the 69,030 participants who took part in the court-ordered community health study to document the leaked chemical’s health effects on affected residents.

WVU research shows promise for reducing risk of breast cancer spreading to the brain

Generally speaking, women diagnosed with breast cancer are surviving longer and having better outcomes. While one in eight women will develop breast cancer during their lifetime, the vast majority will beat the disease. However, 10 to 15 percent of those diagnosed may see their cancer spread to another part of their body. Research led by Paul Lockman, Ph.D., B.S.N., the inaugural Douglas Glover Chair of Pharmaceutical Sciences at the West Virginia University School of Pharmacy and associate director for translational research at the Mary Babb Randolph Cancer Center, seeks to better understand why and how breast cancer can spread to the brain with the goal of developing a way to reduce the risk of this phenomenon.